Global Bio-imaging Market Overview:
Global Bio-imaging Market is expected to grow at a significant rate during the forecast period 2026-2035, with 2024 as the base year.
Global Bio-imaging Market Report 2026 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2026-2035, with base year as 2025. This research study of Bio-imaging involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Bio-imaging Market:
The Bio-imaging Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Bio-imaging Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Bio-imaging Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Bio-imaging market has been segmented into:
Magnetic Resonance Imaging (MRI
By Application, Bio-imaging market has been segmented into:
CT
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Bio-imaging market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Bio-imaging market.
Top Key Players Covered in Bio-imaging market are:
Bracco Imaging S.P.A
Bayer HealthCare Pharmaceuticals
Esaote S.p.A
Digirad Corporation
FONAR Corporation
GE Healthcare
Hologic Inc.
Hitachi Medical Corporation
Lantheus Medical Imaginginc.
Covidien Pharmaceuticals
Mindray Medical International Limited.
Gamma Medica Inc.
Samsung Medison Co. Ltd
Philips Healthcare.
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Bio-imaging Market by Type
4.1 Bio-imaging Market Snapshot and Growth Engine
4.2 Bio-imaging Market Overview
4.3 Magnetic Resonance Imaging (MRI
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Magnetic Resonance Imaging (MRI: Geographic Segmentation Analysis
Chapter 5: Bio-imaging Market by Application
5.1 Bio-imaging Market Snapshot and Growth Engine
5.2 Bio-imaging Market Overview
5.3 CT
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 CT: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Bio-imaging Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 BRACCO IMAGING S.P.A
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 BAYER HEALTHCARE PHARMACEUTICALS
6.4 ESAOTE S.P.A
6.5 DIGIRAD CORPORATION
6.6 FONAR CORPORATION
6.7 GE HEALTHCARE
6.8 HOLOGIC INC.
6.9 HITACHI MEDICAL CORPORATION
6.10 LANTHEUS MEDICAL IMAGINGINC.
6.11 COVIDIEN PHARMACEUTICALS
6.12 MINDRAY MEDICAL INTERNATIONAL LIMITED.
6.13 GAMMA MEDICA INC.
6.14 SAMSUNG MEDISON CO.
6.15 LTD.
6.16 AND PHILIPS HEALTHCARE.
Chapter 7: Global Bio-imaging Market By Region
7.1 Overview
7.2. North America Bio-imaging Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 Magnetic Resonance Imaging (MRI
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 CT
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe Bio-imaging Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 Magnetic Resonance Imaging (MRI
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 CT
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe Bio-imaging Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 Magnetic Resonance Imaging (MRI
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 CT
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific Bio-imaging Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 Magnetic Resonance Imaging (MRI
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 CT
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa Bio-imaging Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 Magnetic Resonance Imaging (MRI
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 CT
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America Bio-imaging Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 Magnetic Resonance Imaging (MRI
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 CT
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Bio-imaging Scope:
|
Report Data
|
Bio-imaging Market
|
|
Bio-imaging Market Size in 2025
|
USD XX million
|
|
Bio-imaging CAGR 2025 - 2032
|
XX%
|
|
Bio-imaging Base Year
|
2024
|
|
Bio-imaging Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Bracco Imaging S.P.A, Bayer HealthCare Pharmaceuticals, Esaote S.p.A, Digirad Corporation, FONAR Corporation, GE Healthcare, Hologic Inc., Hitachi Medical Corporation, Lantheus Medical Imaginginc., Covidien Pharmaceuticals, Mindray Medical International Limited., Gamma Medica Inc., Samsung Medison Co., Ltd., and Philips Healthcare..
|
|
Key Segments
|
By Type
Magnetic Resonance Imaging (MRI
By Applications
CT
|
